PB2258: PHASE 1 FIRST IN HUMAN STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF GRC54276, A NOVEL HPK1 THRONINE-KINASE INHIBITOR, IN ADVANCED SOLID TUMOURS AND LYMPHOMAS.

oleh: Harsha Doddihal, Thomas Marron, Satheesh C T, Manuprasad Avaronnan, Rajnish Nagarkar, Vineet Govinda Gupta, Biju Benjamin, Nagaraj Gowda, Venkatesha Udupa, Nilanjana Biswas, Jatin Kadam, Priyanka Dhage, Adam Beltran, Nikhil Amin